Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39981
Title: | Pseudo-AKI associated with targeted anti-cancer agents-the truth is in the eye of the filtration marker | Authors: | Vanhoutte, Thomas SPRANGERS, Ben |
Issue Date: | 2023 | Publisher: | OXFORD UNIV PRESS | Source: | Clinical Kidney Journal, 16 (4) , p. 603 -610 | Abstract: | Besides true acute kidney injury (AKI), the occurrence of pseudo-AKI has been associated with several targeted agents. To improve the management of cancer patients treated with targeted agents, we need to be aware of this and use diagnostic approaches to differentiate between pseudo-AKI and AKI. In an article by Wijtvliet et al. in this issue of CKJ, tepotinib is added to the list of targeted agents associated with pseudo-AKI. In this editorial we discuss the current literature regarding pseudo-AKI and true AKI associated with targeted agents, and subsequently propose a management strategy to monitor kidney function in patients treated with targeted agents. | Notes: | Sprangers, B (corresponding author), Ziekenhuis Oost Limburg, Genk, Belgium.; Sprangers, B (corresponding author), UHasselt, Biomed Res Inst, Dept Immunol & Infect, Diepenbeek, Belgium. ben.sprangers@zol.be |
Keywords: | acute kidney injury;acute kidney injury;creatinine;creatinine;cystatin C;cystatin C;kidney function;kidney function;targeted therapies;targeted therapies | Document URI: | http://hdl.handle.net/1942/39981 | ISSN: | 2048-8505 | e-ISSN: | 2048-8513 | DOI: | 10.1093/ckj/sfad011 | ISI #: | 000950493000001 | Rights: | © The Author(s) 2023. Published by Oxford University Press on behalf of the ERA. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com | Category: | A2 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Pseudo-AKI associated with targeted anti-cancer agents—the truth is in the eye of the filtration marker.pdf | Published version | 355.43 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.